BRAF and colorectal carcinoma: It is also important to note that, while BRAF V600E is known to be a founder mutation in MMR-D CRC, RAS mutations are not driver alterations in MMR-D CRC and occasionally occur as a result of frameshift mutations; their molecular and clinical significance remains to be seen.